Concord Biotech Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: CONCORDBIO BSE: 543960

About Concord Biotech Limited

Concord Biotech Limited (CBL) is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients (APIs) sold worldwide.

Source: Wikipedia

Key facts

BSE symbol543960
NSE symbolCONCORDBIO
ISININE338H01029
CINL24230GJ1984PLC007440
Listing date18 Aug 2023
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorAshish Shah & Associates (Ashish Shah)
Registered office1482-86 TRASAD ROAD DHOLKA, AHMEDABAD, Gujarat - 382225, India
Index memberships

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24
Total income (before exceptional items)1,108†1,245†1,051†
Net profit263373305

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
ANKUR VAIDExecutive DirectorJune 30, 2026
SUDHIR JAIRAM VAIDExecutive DirectorJune 30, 2026
AMITABH GAJENDRA THAKOREIndependent DirectorJune 30, 2026
ARVIND MOTILAL AGARWALIndependent DirectorJune 30, 2026
BHARTI KHANNAIndependent DirectorJune 30, 2026
CHAKRAVARTHY SRIRAMAN MANDAYAMIndependent DirectorJune 30, 2026
EKTA GUPTAIndependent DirectorJune 30, 2026
JAYARAM EASWARANIndependent DirectorJune 30, 2026
RAJIV AMBRISH AGARWALNon-Executive DirectorJune 30, 2026
RAVI KAPOORNon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.